Literature DB >> 19939615

Factors associated with death 1 year after lower extremity bypass in Northern New England.

Philip P Goodney1, Brian W Nolan, Andres Schanzer, Jens Eldrup-Jorgensen, Andrew C Stanley, David H Stone, Donald S Likosky, Jack L Cronenwett.   

Abstract

BACKGROUND: Using 30-day operative mortality reported with lower extremity bypass (LEB) in preoperative decision making may underestimate the actual death rate encountered before patients have truly recovered from surgery, especially in elderly, debilitated patients with significant tissue loss. Therefore, we examined preoperative, patient-level risk factors that predict survival within the first year following LEB.
METHODS: Using our regional quality improvement initiative in 11 hospitals in Northern New England, we studied 2306 LEB procedures performed in 2031 patients between January 2003 and December 2007. Sixty surgeons contributed to our database, and over 100 demographic and clinical variables were abstracted by trained researchers. Cox proportional hazards models were used to generate hazard ratios (HR) and surrounding 95% confidence intervals (CI) for our combined outcome measure of death occurring within the first year postoperatively.
RESULTS: We found that within our cohort of 2306 bypass procedures, 11% of patients died within 1 year of surgery (2% prior to discharge, 9% prior to 1-year follow-up). We identified six preoperative patient characteristics associated with higher risk of death in multivariate analysis: congestive heart failure (HR 1.3, 95% CI 1.0-1.8), diabetes (HR 1.5, 95% CI 1.1-2.1), critical limb ischemia (CLI) (HR 1.7, 95% CI 1.3-2.4), lack of single-segment saphenous vein (HR 1.9, 95% CI 1.5-2/5), age over 80 (HR 2.0, 95% CI 1.5-2.7), dialysis dependence (HR 2.7, 95% CI 1.9-3.6), and emergent nature of the procedure (HR 3.4, 95% CI 1.7-6.8). While patients with no risk factors had 1-year death rates that were less than 5%: patients with three or more risk factors had a 28% chance of dying before 1 year postoperatively. When we compared risk-adjusted survival across centers, we found that one center in our region performed significantly better than expected (observed-to-expected outcome ratio 0.7, 95% CI 0.6-0.9, P = .04).
CONCLUSIONS: Preoperative risk factors allow surgeons to predict survival in the first year following LEB, and to more precisely inform patients about their operative risk with LEB. Additionally, our model facilitates benchmarking comparison of risk-adjusted outcomes across our region. We believe quality improvement measures such as these will allow surgeons to identify best practices and thereby improve outcomes with LEB across centers. Copyright 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19939615     DOI: 10.1016/j.jvs.2009.07.123

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  18 in total

1.  Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.

Authors:  Lawrence Oresanya; Shoujun Zhao; Siqi Gan; Brant E Fries; Philip P Goodney; Kenneth E Covinsky; Michael S Conte; Emily Finlayson
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

Review 2.  Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.

Authors:  Gnaneswar Atturu; Shervanthi Homer-Vanniasinkam; David A Russell
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

3.  Toe-Brachial Index in the Second Toe: Substitutability to Toe-Brachial Index in the Great Toe and Ankle-Brachial Index.

Authors:  Yoshiko Watanabe; Hisao Masaki; Kenji Kojima; Kazuo Tanemoto
Journal:  Ann Vasc Dis       Date:  2016-11-22

4.  APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.

Authors:  Ellis S Sampram; Anders Gottsäter; Bengt Lindblad; Peter J Svensson
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 5.  Critical limb ischemia: reporting outcomes and quality.

Authors:  Mark G Davies
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Oct-Dec

6.  Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.

Authors:  Catherine K Chang; Salvatore T Scali; Robert J Feezor; Adam W Beck; Alyson L Waterman; Thomas S Huber; Scott A Berceli
Journal:  J Vasc Surg       Date:  2014-07-16       Impact factor: 4.268

7.  Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis.

Authors:  Tze-Woei Tan; Alik Farber; Naomi M Hamburg; Robert T Eberhardt; Denis Rybin; Gheorghe Doros; Jens Eldrup-Jorgensen; Philip P Goodney; Jack L Cronenwett; Jeffrey A Kalish
Journal:  J Am Coll Surg       Date:  2013-03-25       Impact factor: 6.113

8.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

9.  Outcomes of lower extremity bypass performed for acute limb ischemia.

Authors:  Donald T Baril; Virendra I Patel; Dejah R Judelson; Philip P Goodney; James T McPhee; Nathanael D Hevelone; Jack L Cronenwett; Andres Schanzer
Journal:  J Vasc Surg       Date:  2013-05-25       Impact factor: 4.268

10.  Outcomes of lower extremity revascularization among the hemodialysis-dependent.

Authors:  John M Fallon; Philip P Goodney; David H Stone; Virendra I Patel; Brian W Nolan; Jeffrey A Kalish; Yuanyuan Zhao; Allen D Hamdan
Journal:  J Vasc Surg       Date:  2015-08-05       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.